CA2888772A1 - Treatment of pain using amnion derived adherent cells - Google Patents
Treatment of pain using amnion derived adherent cells Download PDFInfo
- Publication number
- CA2888772A1 CA2888772A1 CA2888772A CA2888772A CA2888772A1 CA 2888772 A1 CA2888772 A1 CA 2888772A1 CA 2888772 A CA2888772 A CA 2888772A CA 2888772 A CA2888772 A CA 2888772A CA 2888772 A1 CA2888772 A1 CA 2888772A1
- Authority
- CA
- Canada
- Prior art keywords
- amdacs
- mir
- pain
- cells
- determinable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261716091P | 2012-10-19 | 2012-10-19 | |
| US61/716,091 | 2012-10-19 | ||
| US201361783752P | 2013-03-14 | 2013-03-14 | |
| US61/783,752 | 2013-03-14 | ||
| PCT/US2013/065653 WO2014063035A2 (en) | 2012-10-19 | 2013-10-18 | Treatment of pain using amnion derived adherent cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2888772A1 true CA2888772A1 (en) | 2015-04-24 |
Family
ID=50488901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2888772A Pending CA2888772A1 (en) | 2012-10-19 | 2013-10-18 | Treatment of pain using amnion derived adherent cells |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160166618A1 (https=) |
| EP (1) | EP2909314B1 (https=) |
| JP (4) | JP2015536326A (https=) |
| CA (1) | CA2888772A1 (https=) |
| DK (1) | DK2909314T3 (https=) |
| WO (1) | WO2014063035A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160098244A (ko) * | 2013-11-15 | 2016-08-18 | 안트로제네시스 코포레이션 | 사람 태반 관류액 세포를 포함하는 조성물, 상기 세포의 부분모집단 및 이의 용도 |
| CN113679741B (zh) * | 2021-09-13 | 2023-09-19 | 北京大学第一医院 | 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002542349A (ja) | 1999-04-16 | 2002-12-10 | ダブリューエム・マーシュ・ライス・ユニバーシティー | ポリ(プロピレンフマラート)−ジアクリレートマクロマーで交差結合された生体分解性のポリ(プロピレンフマラート)ネットワーク |
| US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
| EP1790344B1 (en) * | 2000-07-07 | 2011-02-23 | Spectrum Pharmaceuticals, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| EP2316918B1 (en) | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| PL2471907T3 (pl) | 2005-12-29 | 2019-07-31 | Celularity, Inc. | Populacje komórek macierzystych łożyska |
| US20090214484A1 (en) * | 2008-02-22 | 2009-08-27 | Nikolay Mironov | Stem cell therapy for the treatment of central nervous system disorders |
| RU2015130665A (ru) * | 2008-11-19 | 2018-12-24 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
| CA2781649C (en) * | 2009-11-30 | 2017-07-11 | Pluristem Ltd. | Adherent cells from placenta and use of same in disease treatment |
| KR20140022776A (ko) * | 2010-11-16 | 2014-02-25 | 지우세페 마리네오 | 아편제 및 통상적인 전기 진통에 내성이 있는 신경병증 통증, 종양 통증 및 소아 통증을 신속히 억제하기 위한 장치 및 방법 |
| KR20190114045A (ko) * | 2010-12-17 | 2019-10-08 | 안트로제네시스 코포레이션 | 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료 |
| AR084753A1 (es) * | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp) |
-
2013
- 2013-10-18 DK DK13846458.1T patent/DK2909314T3/da active
- 2013-10-18 JP JP2015538056A patent/JP2015536326A/ja active Pending
- 2013-10-18 CA CA2888772A patent/CA2888772A1/en active Pending
- 2013-10-18 WO PCT/US2013/065653 patent/WO2014063035A2/en not_active Ceased
- 2013-10-18 EP EP13846458.1A patent/EP2909314B1/en active Active
- 2013-10-18 US US14/436,746 patent/US20160166618A1/en not_active Abandoned
-
2018
- 2018-07-12 JP JP2018132024A patent/JP2018188456A/ja active Pending
-
2020
- 2020-06-17 JP JP2020104367A patent/JP2020180128A/ja not_active Withdrawn
-
2022
- 2022-06-06 JP JP2022091267A patent/JP7315755B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018188456A (ja) | 2018-11-29 |
| JP2022130406A (ja) | 2022-09-06 |
| JP2020180128A (ja) | 2020-11-05 |
| JP2015536326A (ja) | 2015-12-21 |
| US20160166618A1 (en) | 2016-06-16 |
| WO2014063035A3 (en) | 2014-06-19 |
| EP2909314A2 (en) | 2015-08-26 |
| DK2909314T3 (da) | 2021-03-08 |
| EP2909314A4 (en) | 2016-10-12 |
| JP7315755B2 (ja) | 2023-07-26 |
| HK1214299A1 (en) | 2016-07-22 |
| WO2014063035A2 (en) | 2014-04-24 |
| EP2909314B1 (en) | 2020-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11090339B2 (en) | Treatment of pain using placental stem cells | |
| US8367409B2 (en) | Amnion derived adherent cells | |
| US20120171180A1 (en) | Compositions comprising amnion derived adherent cells and platelet-rich plasma | |
| US20120201787A1 (en) | Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells | |
| JP2016192966A (ja) | 胎盤幹細胞を用いる血管形成 | |
| JP7315755B2 (ja) | 羊膜由来接着細胞を利用する疼痛の治療 | |
| US20230302058A1 (en) | Treatment of lymphedema and related conditions using placental adherent cells | |
| AU2013203199B2 (en) | Amnion derived adherent cells | |
| HK1214299B (en) | Treatment of pain using amnion derived adherent cells | |
| HK1156078B (en) | Amnion derived adherent cells | |
| HK1156078A (en) | Amnion derived adherent cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20181018 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250912 |
|
| R00 | Party data change recorded |
Free format text: ST27 STATUS EVENT CODE: N-6-6-R10-R00-R119 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUEST Effective date: 20251107 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251107 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20251112 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251222 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260107 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260420 |